Reuters logo
BRIEF-Takara Bio signs exclusive license agreement of Oncolytic virus HF10 with Otsuka Pharmaceutical
December 15, 2016 / 6:30 AM / a year ago

BRIEF-Takara Bio signs exclusive license agreement of Oncolytic virus HF10 with Otsuka Pharmaceutical

Dec 15 (Reuters) - Takara Bio :

* Says it signed an exclusive license agreement of Oncolytic virus HF10 with Otsuka Pharmaceutical

* Says it gives development and sale right of HF10 to Otsuka Pharmaceutical

Source text in Japanese: goo.gl/l0GBXC

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below